Doctors report that adding radiotherapy after surgery reduces the risk of recurrence for certain aggressive brain cancers. The reports say cancer returns in almost half of patients without the additional treatment, highlighting the potential impact of post-operative radiotherapy for specific tumour types.
The outlets describe the finding as applying to particular aggressive brain cancers rather than all cases. While both sources focus on the same core result—that post-surgery radiotherapy cuts recurrence risk—they provide limited additional detail on how the benefit is measured or which exact subtypes are included. The overall context is that recurrence rates are high for these tumours, and clinicians look for adjuvant approaches after surgery to improve outcomes.
Both reports frame the evidence around recurrence risk, rather than providing a broader assessment of overall survival or long-term side effects. Any differences in emphasis appear to be limited, with both highlighting radiotherapy’s potential to reduce recurrence after surgical treatment.
